Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with somatostatin receptor expressing neuroendocrine tumors six years' assessment

Mohammadali Hamiditabar, Muzammil Ali, Joseph Roys, Edward M. Wolin, Thomas M. O'Dorisio, David Ranganathan, Izabela Tworowska, Jonathan R. Strosberg, Ebrahim S. Delpassand

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'Peptide receptor radionuclide therapy with <sup>177</sup>Lu-octreotate in patients with somatostatin receptor expressing neuroendocrine tumors six years' assessment'. Together they form a unique fingerprint.

Medicine & Life Sciences